GET FREE CONSULTATION!
+256 704 292188
Imagine a world where even the most isolated villages can access quality, digital healthcare. We spoke to INFUSE winner Signalytic, who are helping digitise medical care across Africa. 1 November 2024 by Diane Abad-Vergara In a world where access to reliable healthcare should be universal, significant barriers still prevent many remote communities in Africa from receiving…
Gestational diabetes mellitus (GDM) is a form of diabetes that occurs during pregnancy, affecting around 14% of pregnant women worldwide and 10% in Switzerland. It is characterized by increased blood sugar levels. “Contrary to the belief that GDM disappears after childbirth, we now know that it can increase the long-term risk of type 2 diabetes…
The mechanisms underlying skin renewal are still poorly understood. Interleukin-38 (IL-38), a protein involved in regulating inflammatory responses, could be a game changer. A team from the University of Geneva (UNIGE) has observed it for the first time in the form of condensates in keratinocytes, the cells of the epidermis. The presence of IL-38 in…
How can we ensure that vital vaccines arrive at their destinations safely? VaccinesWork spoke to INFUSE winner Figorr to learn more about the Nigerian company’s approach. 18 November 2024 by Diane Abad-Vergara Picture this: a truck carrying vital vaccines breaks down in a remote area, risking the integrity of its temperature-sensitive cargo. In traditional logistics, this…
By Shiprah Kwagaka In a bold move to tackle rising teenage pregnancy rates, the Ministry of Health, in partnership with organizations such as USAID, has launched the BOLD Campaign in Namayingo District, Uganda. This youth-centered initiative empowers teens to lead efforts within their communities, transforming former victims into advocates and champions for change. Busoga region,…
In 2020, World Health Organization (WHO) launched the Global strategy to accelerate the elimination of cervical cancer. This was a historic moment, at which all WHO Member States committed to eliminating cancer. This commitment offered hope to many women around the world. Around 660 000 new cases and some 350 000 deaths from this cancer…
The African region is witnessing unprecedented progress in tuberculosis (TB) control, with approximately 70% of cases now being diagnosed and treated. This represents the highest case-detection rate ever achieved in the region, according to the World Health Organization (WHO). As home to 23% of the global TB burden and 33% of TB deaths, Africa’s strides…
Each year, millions of women and children around the world die from preventable causes. Maternal, newborn, and child health (MNCH) is a shared global priority, yet we often overlook one of its most pressing—and preventable—barriers: violence against women. As we mark the 16 Days of Activism Against Gender-Based Violence, we are reminded that gender-based violence…
Pioneering research presented at The Union World Conference on Lung Health has shed light on experimental strategies to combat extensively drug-resistant tuberculosis (XDR-TB). The findings, which span safety, tolerance, and efficacy of new treatment regimens, signal a significant step forward in addressing this challenging global health threat. Tailored Treatments for Pre-XDR TB Results from the…
Breakthrough research presented at The Union World Conference on Lung Health in Bali, Indonesia showcased how artificial intelligence (AI) and computer-aided detection (CAD) technology are transforming tuberculosis (TB) detection across Africa. These innovations are significantly improving active case finding (ACF) efforts, revealing TB incidence rates far higher than national estimates and offering a pathway to…